John Vavricka insider trades
Open-market stock purchases and sales by John Vavricka, Chief Commercial Officer at Atea Pharmaceuticals, Inc, from SEC Form 4 filings since Nov 3, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc | Sold (not open market) | $49.1K |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc | Bought (not open market) | — |
| Jan 31, 2026 | AVIR Atea Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- AVIR Atea Pharmaceuticals, Inc: 1 sale, last Jan 31, 2026